Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/00757033DED0B293BE8084052BD66A505E6E1BE4DEAA235DF3FD7298B05A96F0B498B07A708699B27AB739DCDC2C860Chttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/00757033DED0B293BE8084052BD66A505E6E1BE4DEAA235DF3FD7298B05A96F0B498B07A708699B27AB739DCDC2C860Chttp://www.w3.org/2000/01/rdf-schema#comment"Here the authors report that the expression level of the solute carrier family 3 member 1 (SLC3A1) the cysteine carrier tightly correlated with clinical stages and patients' survival. Elevated SLC3A1 expression accelerated the cysteine uptake and the accumulation of reductive glutathione (GSH) leading to reduced reactive oxygen species (ROS)."xsd:string
http://purl.uniprot.org/uniprot/#_37935F715BF02C8657391867E651FD897C226961A200D88C3489DEDBA156DAA39F92FF61E5F5BCF45FB7799354B2F885http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/00757033DED0B293BE8084052BD66A505E6E1BE4DEAA235DF3FD7298B05A96F0B498B07A708699B27AB739DCDC2C860C
http://purl.uniprot.org/uniprot/A0A0S2Z4E1http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/00757033DED0B293BE8084052BD66A505E6E1BE4DEAA235DF3FD7298B05A96F0B498B07A708699B27AB739DCDC2C860C
http://purl.uniprot.org/uniprot/#_A0A0S2Z4E1-mappedCitation-28382174http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/00757033DED0B293BE8084052BD66A505E6E1BE4DEAA235DF3FD7298B05A96F0B498B07A708699B27AB739DCDC2C860C